Belgian Journal Of Medical Oncology Special, February 2019

Belgian Journal Of Medical Oncology Special, February 2019



Diagnosis of Li-Fraumeni syndrome just in time to prevent iatrogenic secondary cancer

Y. Dockx

Incidence and prognosis of biliary tract and gallbladder cancers in an academic hospital

Quentin Gilliaux

Hemophagocytic lymphohistiocytosis, an unusual initial presentation of a gastric adenocarcinoma with an unusual exclusive bone marrow metastasis

A case report of a psoriasis flare-up during treatment with an immune-checkpoint inhibitor

Boudewijn Dullens

Case report of myopericarditis in a patient treated with an immune checkpoint inhibitor

Lotte Segers

Successful and durable disease control after treatment by peptide receptor radionuclide therapy in a patient with disseminated insulinoma: a case report

Laila Belcaid

Long-term clinical follow-up of breast cancer patients treated with photobiomodulation therapy to prevent acute radiodermatitis (Transdermis trial): Preliminary results

Jolien Robijns

Unexpected timed presentation of dermatomyositis associated with advanced ovarian cancer

Mohammad Fadil Pirbuccus

New hopes generated by Next-generation Sequencing of rare tumors: a case of a metaplastic carcinoma of the breast with mesenchymal and sacomatoid differentiation

Y. Wissam

Progression and complications in melanoma after immunotherapy and corticosteroids treatment

Ionela Bold

When patients with psychiatric disorders decompensate in an oncological setting: a case report

Laila Belcaid

Treating upper digestive bleeding may cause multiple infectious complications in a cancer patient

Lorraine Tulpin

Renal cell carcinoma with TFE3 rearrangement at Xp11.2

Enora Vauléon

One in a million

Sander Smeets

Immune checkpoint inhibitor and kidney transplantation

Maxime Winant

Repeated auto-immune hemolysis elicited by immunotherapy

Hanne Boen

An unusual complete remission of a diffuse metastatic squamous cell cutaneous carcinoma with an EGFR-TKI

Maroun Sadek

Urethral carcinoma: A rare disease but yet no clear guideline for treatment

Laila Belcaid

Autoimmune Thrombocytopenia: Another Toxicity Induced by Immunotherapy

Georges El Hachem

From breast implants to squamous cell carcinoma

Maroun Sadek

A rare tumor of the parotid gland

Maroun Sadek

Genomic profiling of patients with metastatic castration-resistant prostate cancer (mCRPC) for the evaluation of rucaparib: next-generation sequencing (NGS) of tumour tissue and cell-free DNA (cfDNA)

Brieuc Sautois

Ethnic Paradigm in Prostate Cancer - does it really matter?

Fadi Dalati

Treatment algorithm ER positive HER2 negative Advanced Breast Cancer

Guy Jerusalem

Practice changing topics in breast cancer

Francois Duhoux

Practice changing topics in Sarcoma

Christine Gennigens

Topics in gastrointestinal NEN (neuroendocrine neoplasms)

Karen Geboes

Tissue Agnostic Oncology

Hans Prenen

Lessons learned after two decades of international academic clinical research in breast cancer (BC)

Martine Piccart-Gebhart

Clinical outcome and prognostic factors in oligometastatic breast cancer

T. Geukens

Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy

Cynthia D’Hondt

The spatial localization of immune cells predicts prognosis and response to therapy in inflammatory breast cancer

Christophe Van Berckelaer

The role of follicular helper CD4+ T cells in breast cancer anti-tumoral immune response

Mireille Diane Langouo Fontsa

CTC0 in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-directed therapy

Elisabeth De Meue

Real-life value of follow-up FDG-PET/CT (FU-FDG-PET/CT) in patients with locoregionally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with chemoradiation (CRT) or (chemo)radiation ([C]RT) preceded by induction chemotherapy (IC) (sequential treatment [ST]).

Bert Van Den Heuvel

Clinical presentation, natural history and therapeutic approach in patients with solitary fibrous tumor: a retrospective analysis

T. Wessels

Subgroup analysis of rucaparib in platinum-sensitive, recurrent ovarian carcinoma: effect of prior chemotherapy regimens in ARIEL3

Luc Dirix

Opinions of lung cancer patients on tobacco advertising and smoking in public places

Garry Mahon

Neuroendocrine neoplasms grade 3: prospective overall survival data and survival after platinum-etoposide chemotherapy within an ENETS Center of Excellence

W. Lybaert

FGF- R inhibition, a biomarker driven alternative in second line metastatic urothelial cancer

Daan De Maeseneer

The safety of anti-PD1 therapy in a case of paraneoplastic immune disease: a case report

Laila Belcaid